Literature DB >> 25914022

The history and market impact of CRISPR RNA-guided nucleases.

Paul Bg van Erp1, Gary Bloomer2, Royce Wilkinson1, Blake Wiedenheft3.   

Abstract

The interface between viruses and their hosts' are hot spots for biological and biotechnological innovation. Bacteria use restriction endonucleases to destroy invading DNA, and industry has exploited these enzymes for molecular cut-and-paste reactions that are central to many recombinant DNA technologies. Today, another class of nucleases central to adaptive immune systems that protect bacteria and archaea from invading viruses and plasmids are blazing a similar path from basic science to profound biomedical and industrial applications.
Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25914022      PMCID: PMC4470805          DOI: 10.1016/j.coviro.2015.03.011

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  44 in total

Review 1.  Bacteriophage resistance mechanisms.

Authors:  Simon J Labrie; Julie E Samson; Sylvain Moineau
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

2.  How restriction enzymes became the workhorses of molecular biology.

Authors:  Richard J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-19       Impact factor: 11.205

Review 3.  Marine viruses--major players in the global ecosystem.

Authors:  Curtis A Suttle
Journal:  Nat Rev Microbiol       Date:  2007-10       Impact factor: 60.633

Review 4.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

Review 5.  Unravelling the structural and mechanistic basis of CRISPR-Cas systems.

Authors:  John van der Oost; Edze R Westra; Ryan N Jackson; Blake Wiedenheft
Journal:  Nat Rev Microbiol       Date:  2014-06-09       Impact factor: 60.633

6.  Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos.

Authors:  Yuyu Niu; Bin Shen; Yiqiang Cui; Yongchang Chen; Jianying Wang; Lei Wang; Yu Kang; Xiaoyang Zhao; Wei Si; Wei Li; Andy Peng Xiang; Jiankui Zhou; Xuejiang Guo; Ye Bi; Chenyang Si; Bian Hu; Guoying Dong; Hong Wang; Zuomin Zhou; Tianqing Li; Tao Tan; Xiuqiong Pu; Fang Wang; Shaohui Ji; Qi Zhou; Xingxu Huang; Weizhi Ji; Jiahao Sha
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

Review 7.  CRISPR-based technologies: prokaryotic defense weapons repurposed.

Authors:  Rebecca M Terns; Michael P Terns
Journal:  Trends Genet       Date:  2014-02-18       Impact factor: 11.639

8.  Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing.

Authors:  Qiurong Ding; Alanna Strong; Kevin M Patel; Sze-Ling Ng; Bridget S Gosis; Stephanie N Regan; Chad A Cowan; Daniel J Rader; Kiran Musunuru
Journal:  Circ Res       Date:  2014-06-10       Impact factor: 17.367

9.  Precision genome engineering and agriculture: opportunities and regulatory challenges.

Authors:  Daniel F Voytas; Caixia Gao
Journal:  PLoS Biol       Date:  2014-06-10       Impact factor: 8.029

10.  Adenoviral vector delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells.

Authors:  Ignazio Maggio; Maarten Holkers; Jin Liu; Josephine M Janssen; Xiaoyu Chen; Manuel A F V Gonçalves
Journal:  Sci Rep       Date:  2014-05-29       Impact factor: 4.379

View more
  10 in total

1.  The emerging patent landscape of CRISPR-Cas gene editing technology.

Authors:  Knut J Egelie; Gregory D Graff; Sabina P Strand; Berit Johansen
Journal:  Nat Biotechnol       Date:  2016-10-11       Impact factor: 54.908

2.  Programmed Self-Assembly of an Active P22-Cas9 Nanocarrier System.

Authors:  Shefah Qazi; Heini M Miettinen; Royce A Wilkinson; Kimberly McCoy; Trevor Douglas; Blake Wiedenheft
Journal:  Mol Pharm       Date:  2016-02-22       Impact factor: 4.939

Review 3.  Conformational regulation of CRISPR-associated nucleases.

Authors:  Ryan N Jackson; Paul Bg van Erp; Samuel H Sternberg; Blake Wiedenheft
Journal:  Curr Opin Microbiol       Date:  2017-06-21       Impact factor: 7.934

4.  Uncertainty-aware and interpretable evaluation of Cas9-gRNA and Cas12a-gRNA specificity for fully matched and partially mismatched targets with Deep Kernel Learning.

Authors:  Bogdan Kirillov; Ekaterina Savitskaya; Maxim Panov; Aleksey Y Ogurtsov; Svetlana A Shabalina; Eugene V Koonin; Konstantin V Severinov
Journal:  Nucleic Acids Res       Date:  2022-01-25       Impact factor: 16.971

5.  The Emergence of Genome Editing-Innovation Network Dynamics of Academic Publications, Patents, and Business Activities.

Authors:  Natalie Laibach; Stefanie Bröring
Journal:  Front Bioeng Biotechnol       Date:  2022-04-14

Review 6.  CRISPR/Cas system for yeast genome engineering: advances and applications.

Authors:  Vratislav Stovicek; Carina Holkenbrink; Irina Borodina
Journal:  FEMS Yeast Res       Date:  2017-08-01       Impact factor: 2.796

7.  Use of CRISPR systems in plant genome editing: toward new opportunities in agriculture.

Authors:  Agnès Ricroch; Pauline Clairand; Wendy Harwood
Journal:  Emerg Top Life Sci       Date:  2017-11-10

Review 8.  Modern Trends in Plant Genome Editing: An Inclusive Review of the CRISPR/Cas9 Toolbox.

Authors:  Ali Razzaq; Fozia Saleem; Mehak Kanwal; Ghulam Mustafa; Sumaira Yousaf; Hafiz Muhammad Imran Arshad; Muhammad Khalid Hameed; Muhammad Sarwar Khan; Faiz Ahmad Joyia
Journal:  Int J Mol Sci       Date:  2019-08-19       Impact factor: 5.923

Review 9.  Diversity of CRISPR-Cas immune systems and molecular machines.

Authors:  Rodolphe Barrangou
Journal:  Genome Biol       Date:  2015-11-09       Impact factor: 13.583

Review 10.  Novel genetic therapeutic approaches for modulating the severity of β-thalassemia (Review).

Authors:  Fareeha Amjad; Tamseel Fatima; Tuba Fayyaz; Muhammad Aslam Khan; Muhammad Imran Qadeer
Journal:  Biomed Rep       Date:  2020-09-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.